Alan G Walton insider trades: Alexandria Real Estate Equities (ARE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
and 3 more companies
Open-market buys and sales
34 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 8, 2010 | ARE | ↓ Sell | 3,500 | $64.08 | $224K | Direct | Mar 10, 2010 (2d) |
| Feb 18, 2010 | ARE | ↓ Sell | 3,500 | $61.72 | $216K | Direct | Feb 22, 2010 (4d) |
| Nov 13, 2009 | ARE | ↓ Sell | 5,500 | $59.42 | $327K | Direct | Nov 17, 2009 (4d) |
| Nov 10, 2009 | ARE | ↓ Sell | 2,500 | $59.36 | $148K | Direct | Nov 13, 2009 (3d) |
| Oct 18, 2006 | CYKN | ↑ Buy | 833,334 | $1.20 | $1.0M | Direct | Oct 20, 2006 (2d) |
| Oct 17, 2006 | TRBN | ↑ Buy | 41,614 | $13.00 | $541K | Direct | Oct 19, 2006 (2d) |
| Dec 12, 2005 | CMD | ↓ Sell | 1,401,521 | $4.54 | $6.4M | Direct | Dec 14, 2005 (2d) |
| Dec 12, 2005 | CMD | ↓ Sell | 199,753 | $4.54 | $907K | Oxford Bioscience Partners (Bermuda) III | Dec 14, 2005 (2d) |
| Dec 12, 2005 | CMD | ↓ Sell | 131,181 | $4.54 | $596K | Oxford Bioscience Partners (Adjunct) III | Dec 14, 2005 (2d) |
| Dec 12, 2005 | CMD | ↓ Sell | 16,618 | $4.54 | $75K | mRNA Fund L.P. | Dec 14, 2005 (2d) |
| Dec 7, 2005 | CMD | ↓ Sell | 801 | $4.75 | $4K | Direct | Dec 8, 2005 (1d) |
| Dec 7, 2005 | CMD | ↓ Sell | 114 | $4.75 | $542 | Oxford Bioscience Partners (Bermuda) III | Dec 8, 2005 (1d) |
| Dec 7, 2005 | CMD | ↓ Sell | 75 | $4.75 | $356 | Oxford Bioscience Partners (Adjunct) III | Dec 8, 2005 (1d) |
| Dec 7, 2005 | CMD | ↓ Sell | 10 | $4.75 | $48 | mRNA Fund L.P. | Dec 8, 2005 (1d) |
| Nov 30, 2005 | CMD | ↓ Sell | 10,092 | $4.80 | $48K | Direct | Dec 2, 2005 (2d) |
| Nov 30, 2005 | CMD | ↓ Sell | 1,436 | $4.80 | $7K | Oxford Bioscience Partners (Bermuda) III | Dec 2, 2005 (2d) |
| Nov 30, 2005 | CMD | ↓ Sell | 128 | $4.80 | $614 | mRNA Fund L.P. | Dec 2, 2005 (2d) |
| Nov 30, 2005 | CMD | ↓ Sell | 44 | $4.80 | $211 | Oxford Bioscience Partners (Adjunct) III | Dec 2, 2005 (2d) |
| Nov 29, 2005 | CMD | ↓ Sell | 900 | $4.80 | $4K | Oxford Bioscience Partners (Adjunct) III | Dec 2, 2005 (3d) |
| Nov 14, 2005 | CMD | ↓ Sell | 18,903 | $5.00 | $95K | Direct | Nov 16, 2005 (2d) |
| Nov 14, 2005 | CMD | ↓ Sell | 2,690 | $5.00 | $13K | Oxford Bioscience Partners (Bermuda) III | Nov 16, 2005 (2d) |
| Nov 14, 2005 | CMD | ↓ Sell | 1,770 | $5.00 | $9K | Oxford Bioscience Partners (Adjunct) III | Nov 16, 2005 (2d) |
| Nov 14, 2005 | CMD | ↓ Sell | 237 | $5.00 | $1K | mRNA Fund L.P. | Nov 16, 2005 (2d) |
| Oct 4, 2005 | AVRX | ↑ Buy | 145,195 | $10.50 | $1.5M | Direct | Oct 6, 2005 (2d) |
| Oct 4, 2005 | AVRX | ↑ Buy | 20,693 | $10.50 | $217K | Oxford Bioscience Partners (Bermuda) III | Oct 6, 2005 (2d) |
| Oct 4, 2005 | AVRX | ↑ Buy | 13,795 | $10.50 | $145K | Oxford Bioscience Partners (Adjunct) III | Oct 6, 2005 (2d) |
| Oct 4, 2005 | AVRX | ↑ Buy | 1,717 | $10.50 | $18K | mRNA Fund L.P. | Oct 6, 2005 (2d) |
| Sep 26, 2005 | CYKN | ↑ Buy | 2,475,166 | $1.20 | $3.0M | Direct | Sep 28, 2005 (2d) |
| Sep 26, 2005 | CYKN | ↑ Buy | 24,834 | $1.20 | $30K | By mRNA Fund II L.P. | Sep 28, 2005 (2d) |
| Sep 23, 2005 | MEMY | ↑ Buy | 2,605,437 | $1.90 | $5.0M | By Oxford Bioscience Partners IV L.P. | Sep 23, 2005 (0d) |
| Sep 23, 2005 | MEMY | ↑ Buy | 526,316 | $1.90 | $1.0M | By Oxford Bioscience Partners II (Annex) | Sep 23, 2005 (0d) |
| Sep 23, 2005 | MEMY | ↑ Buy | 26,142 | $1.90 | $50K | By mRNA Fund II L.P. | Sep 23, 2005 (0d) |
| Jul 12, 2005 | SLXA | ↑ Buy | 544,536 | $4.00 | $2.2M | Direct | Jul 14, 2005 (2d) |
| Jul 12, 2005 | SLXA | ↑ Buy | 5,464 | $4.00 | $22K | By mRNA Fund II L.P. | Jul 14, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ARE insiders
Open-market trades in the last 12 months
About Alan G Walton's insider trades
Alan G Walton is a director at Alexandria Real Estate Equities (ARE). Since Jul 12, 2005, Alan has reported 13 open-market purchases worth $14.6M and 21 sales worth $9.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (38 filings), other transactions (5 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.